Cardiol Therapeutics Inc.

NASDAQ: CRDL · Real-Time Price · USD
1.33
0.22 (19.82%)
At close: Aug 14, 2025, 3:59 PM
1.36
2.25%
Pre-market: Aug 15, 2025, 07:20 AM EDT

Cardiol Therapeutics Income Statement

Financials in CAD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a 78.76K
Cost of Revenue
n/a 248.35K 219.91K n/a
Gross Profit
n/a -248.35K -219.91K 78.76K
Operating Income
-40.28M -29.79M -50.34M -45.47M
Interest Income
n/a 2.04K 1.24M 106K
Pretax Income
-36.68M -28.13M -30.93M -31.64M
Net Income
-36.68M -28.13M -30.93M -31.64M
Selling & General & Admin
26.26M 15.56M 22.37M 27.87M
Research & Development
14.01M 14.22M 18.96M 10.87M
Other Expenses
n/a 0.00 164.44K 112.23K
Operating Expenses
40.28M 29.79M 41.34M 38.74M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
40.28M 29.79M 41.34M 38.74M
Income Tax Expense
n/a n/a -10.24M -6.91M
Shares Outstanding (Basic)
71.57M 64.46M 62.51M 43.22M
Shares Outstanding (Diluted)
71.57M 64.46M 62.51M 43.22M
EPS (Basic)
-0.51 -0.44 -0.49 -0.73
EPS (Diluted)
-0.51 -0.44 -0.49 -0.73
EBITDA
-40.11M -29.59M -41.16M -38.44M
EBIT
-40.28M -29.79M -41.34M -38.66M
Depreciation & Amortization
162.1K 195.26K 219.91K 220.42K